• / Free eNewsletters & Magazine
  • / My Account

JASDAQ

  1. R-Tech Ueno: Announcement on Acquisition of the Right to Develop and Commercialize DE-105 from Santen Pharmaceutical Co., Ltd.

    R-Tech Ueno: Announcement on Acquisition of the Right to Develop and Commercialize DE-105 from Santen Pharmaceutical Co., Ltd.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.